Your session is about to expire
← Back to Search
Diaphragmatic Breathing for Esophageal Disorders
N/A
Recruiting
Led By Andree Koop, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* patients undergoing high-resolution esophageal manometry
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured for each participant during high-resolution esophageal manometry. data will be collected over the enrollment period of one year.
Awards & highlights
Summary
"This trial aims to find out which body position or movements create the most pressure in a specific part of the esophagus, which can help strengthen the diaphragm."
Who is the study for?
This trial is for patients who are already scheduled to undergo high-resolution esophageal manometry, a test that measures muscle contractions in the esophagus. It's aimed at those with conditions like acid reflux or difficulty swallowing.
What is being tested?
The study is testing how diaphragmatic breathing affects pressure at the EGJ (the valve between the esophagus and stomach). Researchers want to find out which positions or maneuvers increase this pressure most effectively.
What are the potential side effects?
Since the intervention involves only diaphragmatic breathing exercises, no significant side effects are expected. However, discomfort from the manometry procedure itself may occur.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured for each participant during high-resolution esophageal manometry. data will be collected over the enrollment period of one year.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured for each participant during high-resolution esophageal manometry. data will be collected over the enrollment period of one year.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Pressure at the esophagogastric junction
Trial Design
1Treatment groups
Experimental Treatment
Group I: Diaphragmatic breathing protocolExperimental Treatment1 Intervention
All patients will undergo the diaphragmatic breathing protocol with high-resolution esophageal manometry.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
diaphragmatic breathing
2023
N/A
~100
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,298 Previous Clinical Trials
3,958,415 Total Patients Enrolled
Andree Koop, MDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
60 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger